You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
億勝生物科技(01061.HK)正與第三方就共同開發眼科生物藥品展開討論
格隆匯 09-30 19:26

格隆匯 9 月 30日丨億勝生物科技(01061.HK)公告,集團目前正與一名獨立第三方就潛在共同開發眼科生物藥品及相關知識產權許可展開討論。

於本公佈日期,相關訂約方尚未訂立具法律約束力的協議。潛在交易一經落實,或會構成上市規則項下本公司須予披露交易,本公司將於必要時遵循上市規則的相關規定。

董事會亦注意到本公司近期股價有不尋常波動及本公司股份("股份")成交量有所上升。經向本公司作出於相關情況下屬合理查詢後,董事會確認,除潛在交易外,並不知悉可能導致有關股價或成交量波動任何原因,或任何須予公佈以避免股份出現虛假市場的資料,又或根據證券及期貨條例第XIVA部須予披露任何內幕消息。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account